American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

February 02, 2022

Newsletter Sponsor

Alert: On-Demand Unprocessed Bulk Testing Webinar

View our on-demand webinar, Verify the Safety of your Bioreactor with an Expedited UPB Release Testing Strategy, discussing UPB testing approaches, logistics, and regulatory considerations to reduce the risk of contamination from viruses, bacteria, or fungi. Learn about common test methods, testing strategies and turnaround times, use of risk assessments to determine the best strategy, phase-appropriate validation considerations and logistics & execution. Watch now.

	Industry News

Pfizer and Ionis Announce Discontinuation Of Vupanorsen Clinical Development Program
Pfizer Inc. and Ionis Pharmaceuticals, Inc. announced the discontinuation of the Pfizer-led clinical... read more »

AuroMedics Pharma Recalls Polymyxin B for Injection USP, 500,000 Unit per Vial, Due to the Presence of Particulate Matter
AuroMedics Pharma LLC has initiated a voluntary recall of lot number CPB200013 of Polymyxin B for ... read more »

European Commission Approves Teysuno in Metastatic Colorectal Cancer
Nordic Pharma announced that on the 24th of January, the European Commission (EC) approved the new ... read more »

Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy
Waters Corporation has acquired the technology assets and intellectual property rights of Megadalton... read more »

	Infographic

Transition to Recombinant rFC for Endotoxin Testing: The Sustainable Choice
Transition to Recombinant rFC for Endotoxin Testing: The Sustainable Choice
Recombinant Horseshoe Crab Factor C (rFC) provides a sustainable, highly effective, and environmentally friendly sustainable means of endotoxin ... read more »

	Featured Articles

Microbial Control Strategy for iNeST mRNA a Cell-Free, Individualized ATMP Advanced therapy medicinal products (ATMPs) also referred to as Cell and Gene Therapy products (CGT) are a new class of drugs which is fundamentally ... read more »

Five Strategies for Success in Bringing Novel Therapies to Market Advanced therapy medicinal products (ATMPs), as they’re called in the European Union and the UK, or cell and gene therapy products (CGTPs) as they are... read more »

	Featured Video

On-Demand Webinar: Viral Control in Pharmaceutical Processing
This webinar discusses the essential elements of control, testing, and remediation and it includes a spotlight on the maim viruses of concern. watch »

On-Demand Webinar: Disinfectant Efficacy Testing – Coupon/Carrier Method
We aim to provide insight into how the results of a coupon study can be utilized to improve cleaning procedures. watch »

	Featured Products

PURELAB® Chorus 1 Complete Ultrapure Water System
read more »

	Featured Whitepaper

eBook: Tested. Proven. Prepared. Supplying Consistent High-Quality Components Across the Globe
The parenteral market is adapting to a growing need to make products that are more accessible to a wider range of patients. This eBook covers a wide range of topics to help parenteral product ... read more »

	Events

PDA Pharmaceutical Microbiology Conference
Washington, DC – 10/10/2022
The 2022 PDA Pharmaceutical Microbiology Conference continues the ongoing tradition of addressing the most relevant opportunities and challenges to ... event details »

IFPAC
North Bethesda, Maryland – 02/27/2022
IFPAC brings together experienced professionals and the next generation of leaders to share in discussions, give input and get ideas for the future ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA